Multiple Sclerosis

Treatment, research and what you can do yourself. The outlook has never been better.

Updated: June 2026

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. The immune system mistakenly attacks the protective sheath of the nerve fibers (myelin) in the brain and spinal cord. Depending on where the damage occurs, very different symptoms appear. In Germany, about 250,000 people live with MS.

An important message up front: an MS diagnosis today is no longer what it was 20 years ago. With early, consistent treatment, many people with MS lead a largely normal life.

Conventional Medicine as the Foundation

Today there are about 20 approved drugs that influence the course of the disease. Especially right after a diagnosis, they are the most important foundation. Highly effective antibodies such as ocrelizumab can almost completely suppress relapses in many patients.

The next generation is BTK inhibitors such as tolebrutinib and fenebrutinib, tablets that reach the brain and are meant to also slow the gradual progression. The approval process has been bumpy: the European agency EMA rated tolebrutinib positively, while the US FDA initially rejected the application.

Research

More Intensive and Alternative Approaches

What You Can Do Yourself

Everything below supplements the treatment but does not replace it:

My Conclusion

Just like with my Parkinson's: the best strategy is a combination of modern medicine and a consistently healthy lifestyle. After a new diagnosis, first go to a good MS center and start an effective therapy early.